ABHD15-AS1

Across TCGA pan-cancer cohorts, ABHD15-AS1 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated ABHD15-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ABHD15-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ABHD15-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and STAD show a favorable association.

BLCA, SKCM, and PCPG are the cancer types where ABHD15-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.680	0.376	.001	48	view →
SKCM	DFS	Tertile	IV	0.085	0.548	.001	45	view →
PCPG	OS	Tertile	All	0.647	0.969	.005	24	view →
COAD	OS	Tertile	II,III,IV	0.206	0.577	.020	21	view →
OV	OS	Quartile	IV	0.409	0.693	.003	18	view →
LAML	DFS	Tertile	All	0.356	0.665	.008	18	view →
UCEC	DFS	Tertile	All	0.638	0.662	.041	12	view →
GBM	DFS	Tertile	All	0.105	0.303	.005	9	view →
UVM	DFS	Tertile	III,IV	0.071	0.636	<.001	9	view →
STAD	OS	Tertile	IV	0.652	0.317	.039	9	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	6	view →
LUAD	DFS	Quartile	III,IV	0.864	0.602	.037	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

ABHD15-AS1–BLCA (OS)

Open the BLCA breakdown →